Imaging Tests to Support GLP-1 Treatment

Primary Care
Menu

Supporting Your Path to GLP-1 Treatment

If you’re exploring GLP-1 medications for weight management, your provider may recommend imaging tests to help support insurance approval.

These tests provide a more complete picture of your health beyond BMI alone. They can help document body composition and metabolic health, which are factors many insurance plans consider when reviewing coverage for GLP-1 medications.

While imaging does not guarantee approval, it can strengthen the documentation your provider submits during the authorization process.

How Eligibility Imaging May Help

Eligibility imaging can help:

  • Provide objective medical information beyond BMI
  • Document body fat distribution and metabolic risk factors
  • Support medical necessity documentation for insurance review
  • Strengthen prior authorization or appeal requests
  • Establish a baseline to track progress over time

These tests are typically used alongside your provider’s evaluation, diagnosis, and documentation of prior lifestyle efforts, such as nutrition and physical activity.

Liver Elastography Ultrasound

A liver elastography ultrasound is a noninvasive test that evaluates liver health by measuring the stiffness of liver tissue. This can help identify conditions often associated with metabolic health and weight-related risks.

This test:

  • Uses ultrasound technology
  • Does not involve radiation
  • Is quick and comfortable
  • Helps detect liver changes linked to metabolic conditions

This information may help provide additional clinical context related to your overall metabolic health.

DEXA Body Composition Scan

A DEXA body composition scan provides a detailed view of your body’s fat, muscle, and bone. Unlike BMI, which only considers height and weight, a DEXA scan offers a more precise look at body composition.

A DEXA scan measures:

  • Total body fat percentage
  • Visceral fat (fat around internal organs)
  • Muscle mass
  • Bone density

This helps your provider better understand how weight is distributed and identify potential metabolic risks.

For some patients, this information may help demonstrate obesity-related health risks, even when BMI alone does not fully reflect overall health.

Talk with Your Provider

Eligibility imaging may provide helpful information to support your treatment plan and insurance review. If you’re interested in GLP-1 therapy, talk with your provider about whether these tests may be appropriate for you.